KAESHA TRAYNOR: Open Payments
NPI 1548951114 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 21 payments from 13 companies in 2025. Trend: 2023 $38 · 2024 $71 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $59 |
| Indivior Inc. | 3 | $58 |
| Astellas Pharma US Inc | 2 | $45 |
| ViiV Healthcare Company | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Seqirus USA Inc | 1 | $28 |
| Amgen Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $19 |
Products named: SUBLOCADE, Veozah, VIVITROL, APRETUDE, CAPLYTA, REXULTI, Fluad, OTEZLA.
Industry payments across CO — which companies pay providers there.
